Danaher Corporation Stock NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 142B 125B 115B 106B 200B 13,726B 203B 1,379B 541B 6,716B 534B 523B 23,138B | P/E 2026 * |
32.7x | P/E 2027 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 164B 144B 133B 123B 231B 15,858B 235B 1,593B 624B 7,759B 617B 604B 26,732B | EV / Sales 2026 * |
6.26x | EV / Sales 2027 * | 5.47x |
| Free-Float |
71.14% | Yield 2026 * |
0.71% | Yield 2027 * | 0.76% |
Last Transcript: Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 2020-08-31 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 2026-02-27 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 1999-06-30 |
Steven Rales
CHM | Chairman | 74 | 1983-12-31 |
Mitchell Rales
BRD | Director/Board Member | 69 | 1983-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 142B | |
| -1.17% | -0.43% | +26.88% | -2.24% | 196B | |
| +2.24% | -13.25% | -31.90% | +1.58% | 125B | |
| -0.59% | -1.97% | -57.77% | -18.13% | 65.06B | |
| -0.85% | -7.40% | +11.13% | -8.26% | 48.94B | |
| -1.90% | +1.17% | -24.26% | -32.43% | 44.9B | |
| -0.91% | -2.82% | +14.27% | +4.58% | 36.79B | |
| -3.10% | -4.20% | +24.35% | +27.80% | 35.11B | |
| -0.19% | +0.06% | -23.00% | -9.43% | 28.65B | |
| -0.38% | -3.80% | -17.29% | -23.24% | 28.58B | |
| Average | -1.19% | -3.69% | -8.62% | -6.64% | 67.63B | |
| Weighted average by Cap. | -1.32% | -3.82% | -4.62% | -5.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.25B 23.01B 21.27B 19.56B 36.91B 2,532B 37.5B 254B 99.69B 1,239B 98.58B 96.43B 4,267B | 28.68B 25.14B 23.24B 21.37B 40.32B 2,766B 40.97B 278B 109B 1,353B 108B 105B 4,662B |
| Net income | 4.39B 3.85B 3.56B 3.27B 6.17B 423B 6.27B 42.54B 16.68B 207B 16.49B 16.13B 714B | 5.53B 4.85B 4.48B 4.12B 7.78B 533B 7.9B 53.58B 21B 261B 20.77B 20.31B 899B |
| Net Debt | 22.11B 19.38B 17.91B 16.47B 31.08B 2,132B 31.58B 214B 83.95B 1,043B 83.01B 81.2B 3,593B | 14.57B 12.77B 11.8B 10.85B 20.48B 1,405B 20.81B 141B 55.32B 687B 54.7B 53.5B 2,368B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
